Clinical Trial Update: Tigulixostat (IBI128) vs Febuxostat in Gout [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial comparing Tigulixostat (IBI128) to Febuxostat for gout is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gout

Drugs mentioned

• FEBUXOSTAT (Febuxostat)
• Tigulixostat (tigulixostat)

Snippet

Sponsor: Innovent Biologics Technology Limited (Shanghai R&D Center) | Conditions: Gout | Phase 3 | Status: RECRUITING